8
given an appropriate electrophilic partner, and therefore,
targetable for direct acylation. As we ideally wished to
maintain polyketide-like functionality in the product, ꢀ-lac-
tones seemed most suitable. The work described herein
provides a greatly simplified alternative to traditional means
of selectively loading ACPs.
The simplest test of selective Ppant acylation is to expose
our reagents to isolated holo- and apo-ACP domains.
Successful agents will exhibit selectivity for the holo
structures, without nonspecific acylation of the apo ones. To
begin assessing our direct acylation approach, an alkyne-
bearing ꢀ-lactone, compound 1 (Figure 1), was prepared
small molecules in vitro. Thorough trypsinolysis of apo-
and holo-ACPs produced a series of peptide fragments
including one containing the conserved DSL motif, to which
the Ppant is attached in samples derived from BAP1 as
determined by LC-MS (see the Supporting Information).
Incubation of holo-ACP2 and -3 with varied equivalents of
1 at pH 7 for 1 h followed by exhaustive trypsinolysis and
LC-MS, to determine the fraction acylated, produced satura-
tion curves which indicated that a roughly 50-fold excess of
lactone is required for complete acylation (Figure 2).
Figure 2
mass spectrometry for ACP3 (yellow), ACP2 (blue), and KS-AT6
red) with compound 1. Equivalents of lactone are per protein
molecule. Each data point is the average of three experiments.
Standard deviations are shown as black error bars. Lines are added
for clarity.
. Saturation curves as determined by tandem proteolysis-
Figure 1
acyl-carrier proteins.
. Structures of ꢀ-lactones prepared for direct acylation of
(
5
according to the method of Nelson and co-workers. Isolated
ACP domains from modules 2 (ACP2) and 3 (ACP3) of the
6
-deoxyerythronolide B synthase (DEBS) were overex-
Gratifyingly, both apo-ACPs showed no acylation with 50
equiv of lactone, providing further evidence that the reaction
is occurring on the Ppant arm as this is the only difference
between the apo and holo forms of ACP (see the Supporting
Information). The analogous saturation curve for KS-AT6
showed 25-50% less acylation than ACP for the range of
lactone equivalents tested. Most importantly, at 10 lactone
equivalents, the ACPs were approximately 35-50% loaded
while the KS was mostly unreactive after 1 h of incubation.
Standard deviations for these experiments were generally
within 1-4% suggesting that the differential reactivity
observed was genuine.
pressed and purified in both apo and holo forms, using BL21
and BAP1 cells, repectively.
Of course, to be truly useful, our probes must avoid
reaction with nucleophiles present on other common PKS
domains. Since KS active site cysteines have been previously
shown to be competent nucleophiles for ꢀ-lactone ring-
opening, a KS-AT didomain from DEBS module 6 (KS-
AT6) was overexpressed and purified as previously reported.
We were encouraged by the previous report of Sieber and
co-workers where minimal reactivity between compound 1
and the KS domain of bacterial fatty acid synthase was
6
7
6
observed. It remained to be seen, however, whether the
While tandem proteolysis/LC-MS confirms acylation of
the PPant group, not all proteolysis products readily ionize
under the conditions used. In addition, we could not rule
out the potential for acylation of the peptide fragments over
the intact protein. Therefore, an alternative, gel-based assay
was designed according to previous work by Sieber and co-
purified DEBS KS domain would behave in a similar fashion.
The stage was now set to examine both efficiency and
selectivity of ACP-acylation with ꢀ-lactones.
Tandem proteolysis-mass spectrometry has been shown
previously to be a powerful means of detecting PKS-bound
6
workers. Each ACP (apo and holo) and KS-AT6 was
(
5) Nelson, S. G.; Wan, Z.; Peelen, T. J.; Spencer, K. L. Tetrahedron
Lett. 1999, 40, 6535–6539.
(
(
6) Bottcher, T.; Sieber, S. A. Angew. Chem., Int. Ed. 2008, 47, 4600.
(8) (a) Schnarr, N. A.; Chen, A. Y.; Cane, D. E.; Khosla, C. Biochemistry
2005, 44, 11836. (b) Hicks, L. M.; O’Connor, S. E.; Mazur, M. T.; Walsh,
C. T.; Kelleher, N. L. Chem. Biol. 2004, 11, 327. (c) Hong, H.; Appleyard,
A. N.; Siskos, A. P.; Garcia-Bernardo, J.; Staunton, J.; Leadlay, P. F. FEBS
J. 2005, 272, 2373.
7) (a) Kim, C.-Y.; Alekeyev, V. Y.; Chen, A. Y.; Tang, Y.; Cane, D. E.;
Khosla, C. Biochemistry 2004, 43, 13892–13898. (b) Chen, A. Y.; Schnarr,
N. A.; Kim, C.-Y.; Cane, D. E.; Khosla, C. J. Am. Chem. Soc. 2006, 128,
3
067–3074.
Org. Lett., Vol. 12, No. 10, 2010
2331